Autonomy Bio Overview
- Year Founded
-
2024
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$17M
- Investors
-
2
Autonomy Bio General Information
Description
Operator of a drug discovery company designed to develop human aging drugs. The company aims to adopt an approach that combines existing FDA-approved drug classes, enabling medical companies to start clinical trials while reducing development risks.
Contact Information
Website
www.autonomybio.comCorporate Office
- 512 2nd Street
- Floor 3
- San Francisco, CA 94107
- United States
Corporate Office
- 512 2nd Street
- Floor 3
- San Francisco, CA 94107
- United States
Autonomy Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 27-Mar-2025 | $17M | Completed | Startup |
Autonomy Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 2 | ||||||||
| Seed 1 |
Autonomy Bio Signals
Autonomy Bio Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| One Capital (Tokyo) | Venture Capital | Minority | ||
| Valhalla Ventures | Venture Capital | Minority |
Autonomy Bio FAQs
-
When was Autonomy Bio founded?
Autonomy Bio was founded in 2024.
-
Where is Autonomy Bio headquartered?
Autonomy Bio is headquartered in San Francisco, CA.
-
What is the size of Autonomy Bio?
Autonomy Bio has 4 total employees.
-
What industry is Autonomy Bio in?
Autonomy Bio’s primary industry is Drug Discovery.
-
Is Autonomy Bio a private or public company?
Autonomy Bio is a Private company.
-
What is the current valuation of Autonomy Bio?
The current valuation of Autonomy Bio is .
-
What is Autonomy Bio’s current revenue?
The current revenue for Autonomy Bio is .
-
How much funding has Autonomy Bio raised over time?
Autonomy Bio has raised $17M.
-
Who are Autonomy Bio’s investors?
One Capital (Tokyo) and Valhalla Ventures have invested in Autonomy Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process